Litigation

Recent Posts

And The Beat Goes On. . . Medicaid Fraud Suits Continue Churning and Returning Taxpayer Money Paid To Medical Providers
Posted on 11 Sep 2012 by LexisNexis Litigation Resource Community Staff

In anticipation of the upcoming U.S. presidential election, the news cycle is heating up with discussions about federal and state budget deficits and funding for Medicare/Medicaid programs. Both the Republican and Democratic Parties are lining up and... Read More

Tags: LexisNexis Jury Verdicts and Settlements Team , False Claims Act , Medicare , Insurance Fraud , Abbott Laboratories , verdicts and settlements , United States , Fraud , Medicaid , SCAN Health Plan , NextCare , LexisNexis , Litigation , GlaxoSmithKline , qui tam , ex rel. Greg Thorpe v. GlaxoSmithKline , DaVita Inc. , medical providers , express scripts

DLA Piper: 9th Circuit Joins Majority Of Circuits To Lower Barrier For Whistleblowers In False Claims Act Lawsuits
Posted on 4 Aug 2015 by DLA Piper

By Todd C. Toral and Greg Young The U.S. Court of Appeals for the Ninth Circuit, in a case likely heralding an increase in the number of qui tam False Claims Act lawsuits, has abrogated prior precedent and lowered the jurisdictional bar for whistleblowers... Read More

Tags: False Claims Act , FCA , health care , United States ex rel. Hartpence v. Kinetic Concepts , California , Whistleblowers , DLA Piper , Litigation , Ninth Circuit , qui tam

Foley & Lardner LLP: 7th Circuit Rejects Public-Disclosure Bar in Qui Tam Case
Posted on 19 Aug 2014 by Foley & Lardner LLP

By Eric G. Pearson A cardinal rule of a qui tam action brought under the False Claims Act is that the relator must be the information’s original source. In United States ex rel. Heath v. Wisconsin Bell, Inc. , No. 12-3383 (7th Cir. July 28... Read More

Tags: False Claims Act , Telecommunications Act of 1996 , Affordable Care Act , health care , Obamacare Foley & Lardner , Health Care Reform , whistleblower , Wisconsin Bell , Litigation , Inc. , In United States ex rel. Heath v. Wisconsin Bell , qui tam , Wisconsin , torts

Williams Mullen Alert: For Whom the Whistle Blows: Analysis Of The American Apparel Shareholder Derivative Litigation From A Whistleblower Perspective
Posted on 13 Aug 2012 by Williams Mullen

By Mary Pivec and Igor M. Babichenko I. INTRODUCTION On July 31, 2012, the United States District Court for the Central District of California dismissed without prejudice a shareholder derivative suit against American Apparel and its individual directors... Read More

Tags: Immigrations and Customs Enforcement. ICE , Securities and Exchange Commission , Williams Mullen , whistleblower , SEC , Litigation , Sylvester v. Paraxel , qui tam , American Apparel Shareholder Derivative Litigation , Securities

DLA Piper LLP: Appeals Court Clarifies Attorney-Client, Work Product Privileges In Internal Investigation Context
Posted on 14 Aug 2015 by DLA Piper

By Jonathan W. Haray , Jeffrey D. Rotenberg and Lindsay R. Barnes In its latest review of the attorney-client and work product privileges in In re: Kellogg Brown & Root, Inc. (“ In re KBR ”), the US Court of Appeals for the DC Circuit... Read More

Tags: In re: Kellogg Brown & Root , False Claims Act , attorney-client privilege , In re KBR , DLA Piper , work product privilege , Litigation , Inc. , qui tam , torts

Novartis To Pay $422.5M For Off-Label Promotion Of 6 Drugs
Posted on 1 Oct 2010 by Tom Moylan

PHILADELPHIA -- Novartis Pharmaceuticals Corp. will pay $422.5 million in criminal and civil penalties to resolve off-label marketing allegations for six drugs, the federal government announced Sept. 30 ( United States of America v. Novartis Pharmaceuticals... Read More

Tags: False Claims Act , irritable bowel syndrome drug , antiepileptic drug Trileptal , anti-growth hormone drug , Tekturna , hypertension drugs , Diovan , Jim Austin , Litigation , Novartis. off-label marketing , lawsuit , Sandostatin , qui tam , Steve McKee , Darryl Copeland , Zelnorm , Jeremy Garrity , Department of Health and Human Services , Exforge

William A. Ruskin: First Amendment Bars Pharmaceutical Company Prosecution
Posted on 14 Dec 2012 by William A. Ruskin

By William A. Ruskin The Second Circuit [on Dec. 3] rendered its much-anticipated decision in United States v. Caronia [ enhanced version available to lexis.com subscribers ], the most important Food Drug and Cosmetics Act enforcement case pending... Read More

Tags: False Claims Act , Second Circuit , off-label promotion , Drug & Medical Device , misbranding , Stuart Gerson , William A. Ruskin , FDCA , Litigation , Food Drug and Cosmetics Act , United States v Caronia , qui tam , First Amendment

Employer Compliance Guidance for Whistleblower Provisions Under New Food Safety Modernization Act
Posted on 11 Jan 2011 by Keller and Heckman LLP

As previously reported by Keller and Heckman LLP, President Obama signed the Food Safety Modernization Act (FSMA) into law on January 4, 2011. While most of the provisions regarding stricter food safety standards will not be effective until 2012, FSMA... Read More

Tags: retaliation , Food and Drug Administration , food safety , FDA , whistleblower , Food Safety Modernization Act , Keller and Heckman LLP , Litigation , lawsuit , adverse job actions , qui tam , FSMA

Foley & Lardner LLP: 8th Circuit Dismisses Whistleblower's Suit Finding Facts Were Already Publicly Disclosed
Posted on 19 Aug 2014 by Foley & Lardner LLP

By Jacqueline N. Acosta In an August 7, 2014 opinion, the Eighth Circuit upheld the dismissal of a whistleblower’s suit alleging that a number of pain pump device makers had violated the False Claims Act (FCA) by marketing their pain pumps for... Read More

Tags: False Claims Act , Medicare , FCA , Eighth Circuit , Foley & Lardner , United States ex rel. Paulos v. Stryker Corp. , personal injury , pain pump devices , Florida , Fourth Circuit , whistleblower , Medicaid , Litigation , United States ex rel. Ahumada v. NISH , qui tam , torts

Russell Budd Announces Opening Of Baron & Budd P.C. Office In Miami
Posted on 10 Aug 2010 by LexisNexis Litigation Resource Community Staff

MIAMI - Russell Budd has announced the opening of plaintiff's law firm Baron & Budd, P.C. 's new office in Miami. The new office will offer its services to individuals and businesses with environmental issues as well as those victimized... Read More

Tags: Chinese Drywall , drugs , Russell Budd , environmental , pharmaceutical injuries , personal injury , BP Gulf Oil Spill , California Proposition 65 , Miami law firms , Robert Brown , Baron & Budd , Miami attorneys , water contamination , asbestos , Litigation , securities fraud , qui tam , torts , Insurance Claims

R. Scott Oswald Elected President Of MWELA
Posted on 16 Feb 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - R. Scott Oswald , managing principal of The Employment Law Group law firm, has been elected to serve as the 2011-2012 president of the Metropolitan Washington Employment Lawyers Association (MWELA). MWELA is the 300-lawyer Washington... Read More

Tags: False Claims Act , Sarbanes-Oxley , Equal Employment Opportunity , Washington law firms , Employment Law , Fair Labor Standards Act , FMLA , R. Scott Oswald , whistleblower , Family and Medical Leave Act , Litigation , The Employment Law Group , SOX , Metropolitan Washington Employment Lawyers Association , MWELA , qui tam , Uniformed Services Employment and Reemployment Rights Act , Washington lawyers

U.S. Joins False Claims Act Lawsuit Against Georgia Medical Center And Physician
Posted on 23 Apr 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. — The United States has intervened in a False Claims Act lawsuit alleging that Satilla Health Services Inc., dba Satilla Regional Medical Center, and Dr. Najam Azmat submitted claims for medically substandard and unnecessary services... Read More

Tags: Satilla Health Services Inc. , False Claims Act , Medicare , Lana Rogers , Satilla Heart Center , Office of Inspector General , new lawsuit filings , Dr. Najam Azmat , whistleblower , Justice Department , Medicaid , Litigation , lawsuit , qui tam , U.S. Attorney's Office for the Southern District of Georgia , Satilla Regional Medical Center , Department of Health and Human Services